Massimo Donadelli

19PUBLICATIONS
55CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models.

|Oct 28, 2025
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells.

Federica Danzi, Giovanna Butera, Damien Sutton

|Aug 17, 2025
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells.

Maria Poles, Raffaella Pacchiana, Chiara Mortali

|May 13, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.

Dimas Carolina Belisario, Muhlis Akman, Martina Godel

|Oct 25, 2024
Microgravity as a Tool to Investigate Cancer Induction in Pleura Mesothelial Cells.

Valentina Bonetto, Corinna Anais Pagano, Maurizio Sabbatini

|Feb 10, 2024
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

Alessandra De Feo, Marcello Manfredi, Caterina Mancarella

Pageof 4

Frequent Collaborators

4 joint publications

Chiara Riganti

3 joint publications

Marco Cordani

2 joint publications

Miguel Sánchez-Álvarez

2 joint publications

Alexandr V Bazhin